Topic Highlight
Copyright ©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 14, 2014; 20(14): 3950-3959
Published online Apr 14, 2014. doi: 10.3748/wjg.v20.i14.3950
Table 1 The distribution of somatic mitochondrial DNA mutations in human cancers n (%)
CancerCasesNo. of cancers with mutationNo. of mutationsD-looprRNAtRNAmRNARef.
Adult leukemia249 (37.5)92 (22.2)1 (11.1)06 (66.7)[16]
Bladder cancer149 (64.3)206 (30.0)3 (15.0)011 (55.0)[17]
Breast cancer1811 (61.1)127 (58.3)005 (41.7)[18]
1914 (73.7)2722 (81.5)1 (3.7)04 (14.8)[19]
1514 (93.3)4517 (37.8)3 (6.7)2 (4.4)23 (51.1)[20]
5827 (46.6)4021 (52.5)2 (5.0)2 (5.0)15 (37.5)[21]
Esophageal cancer2011 (55.0)149 (64.3)1 (7.1)04 (28.6)[22]
Follicular thyroid cancer33 (100.0)42 (50.0)2 (50.0)00[23]
Gastric cancer3120 (64.5)2618 (69.2)01 (3.8)7 (26.9)[15]
Head-and-neck cancer136 (46.2)96 (66.7)1 (11.1)02 (22.2)[17]
Hepatocellular cancer105 (50.0)2423 (95.8)001 (4.2)[24]
4423 (52.3)3421 (61.8)1 (2.9)2 (5.9)10 (29.4)[25]
Lung cancer146 (47.1)107 (70.0)1 (10.0)2 (20.0)0[17]
5533 (60.0)5618 (32.1)1 (1.8)3 (5.4)34 (60.7)[26]
Medulloblastoma156 (40.0)1811 (61.1)03 (16.7)4 (22.2)[27]
Oncocytic head-and-neck tumor2516 (64.0)1800018 (100.0)[28]
Oncocytic pituitary adenoma2518 (72.0)203 (15.0)02 (10.0)15 (75.0)[28]
Oncocytic thyroid tumor4526 (57.8)3000030 (100.0)[29]
Oral cancer1814 (77.8)2620 (76.9)006 (23.1)[30]
300240 (80.0)645355 (55.0)36 (5.6)21 (3.3)233 (36.1)[31]
Ovarian cancer106 (60.0)1511 (73.3)3 (20.0)01 (6.7)[32]
Pancreatic cancer54 (80.0)401 (25.0)1 (25.0)2 (50.0)[33]
Papillary thyroid cancer73 (42.9)40004 (100.0)[23]
Parathyroid adenoma3015 (50.0)276 (22.2)1 (3.3)1 (3.3)19 (70.4)[34]
Renal cell cancer85 (62.5)61 (16.7)2 (33.3)03 (50.0)[35]
97 (77.8)94 (44.4)1 (11.1)1 (11.1)3 (33.3)[36]
157 (46.7)144 (28.6)4 (28.6)1 (7.1)5 (35.7)[37]
Renal oncocytomas99 (100.0)141 (7.1)0013 (92.9)[38]
Total859567 (66.0)1180595 (50.5)65 (5.5)42 (3.6)478 (40.4)
Table 2 The types of somatic mitochondrial DNA mutations in human cancers n (%)
CancerCasesNo. of cancers with mutation (%)No. of mutationsTransitionsTransversionsMono-/di-nucleotide repeat instabilityOthersRef.
Adult leukemia249 (37.5)99 (100.0)000[16]
Bladder cancer149 (64.3)2014 (70.0)3 (15.0)1 (5.0)2 (10.0)[17]
Breast cancer1811 (61.1)126 (50.0)1 (8.3)5 (41.7)0[18]
1914 (73.7)2722 (81.5)1 (3.7)4 (14.8)0[19]
1514 (93.3)4533 (73.3)7 (15.6)5 (11.1)0[20]
5827 (46.6)4020 (50.0)2 (5.0)17 (27.5)1 (2.5)[21]
Esophageal cancer2011 (55.0)143 (21.4)1 (7.1)9 (64.3)1 (7.1)[22]
Follicular thyroid cancer33 (100.0)43 (75.0)01 (25.0)0[23]
Gastric cancer3120 (64.5)2612 (46.2)012 (46.2)2 (7.7)[15]
Head-and-neck cancer136 (46.2)97 (77.8)02 (22.2)0[17]
Hepatocellular cancer105 (50.0)2415 (62.5)09 (37.5)0[24]
4423 (52.3)3419 (55.9)013 (38.2)2 (5.9)[25]
Lung cancer146 (47.1)108 (80.0)1 (10.0)1 (10.0)0[17]
5533 (60.0)5647 (83.9)1 (1.8)8 (14.3)0[26]
Medulloblastoma156 (40.0)1813 (72.2)05 (27.8)0[27]
Oncocytic head-and-neck tumor2516 (64.0)1813 (72.2)1 (5.6)1 (5.6)3 (16.7)[28]
Oncocytic pituitary adenoma2518 (72.0)2010 (50.0)09 (45.0)1 (5.0)[28]
Oncocytic thyroid tumor4526 (57.8)3022 (73.3)1 (3.3)5 (15.2)2 (6.7)[29]
Oral cancer1814 (77.8)2612 (46.2)4 (15.4)8 (30.8)2 (14.3)[30]
300240 (80.0)645356 (55.2)20 (3.1)237 (36.7)32 (5.0)[31]
Ovarian cancer106 (60.0)1510 (66.7)04 (26.7)1 (6.7)[32]
Pancreatic cancer54 (80.0)43 (75.0)1 (25.0)00[33]
Papillary thyroid cancer73 (42.9)44 (100.0)000[23]
Parathyroid adenoma3015 (50.0)2718 (66.7)1 (3.7)6 (22.2)2 (7.4)[34]
Renal cell cancer85 (62.5)62 (33.3)1 (16.7)1 (16.7)2 (33.3)[35]
97 (77.8)96 (66.7)03 (33.3)0[36]
157 (46.7)1413 (92.9)1 (7.1)00[37]
Renal oncocytomas99 (100.0)147 (50.0)2 (14.3)4 (28.6)1 (7.1)[38]
Total859567 (66.0)1180707 (59.9)49 (4.2)370 (31.4)54 (4.6)